Spots Global Cancer Trial Database for myasthenia gravis, generalized
Every month we try and update this database with for myasthenia gravis, generalized cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG) | NCT03759366 | Myasthenia Grav... Myasthenia Grav... Myasthenia Grav... | Eculizumab | 6 Years - 17 Years | Alexion Pharmaceuticals, Inc. | |
| Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis | NCT05067348 | Myasthenia Grav... | Tocilizumab Inj... | 18 Years - 80 Years | Tang-Du Hospital | |
| Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis | NCT05067348 | Myasthenia Grav... | Tocilizumab Inj... | 18 Years - 80 Years | Tang-Du Hospital | |
| Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis | NCT02565576 | Myasthenia Grav... | Placebo CFZ533 | 18 Years - 85 Years | Novartis | |
| A Study to Evaluate the Efficacy of CV-MG01 (Myasterix) in Myasthenia Gravis | NCT03165435 | Myasthenia Grav... | CV-MG01 Placebo | 18 Years - | CuraVac | |
| The Impact of Myasthenia Gravis in the Real World | NCT04176211 | Myasthenia Grav... | 18 Years - | Vitaccess Ltd | ||
| The Impact of Myasthenia Gravis in the Real World | NCT04176211 | Myasthenia Grav... | 18 Years - | Vitaccess Ltd | ||
| A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG) | NCT03759366 | Myasthenia Grav... Myasthenia Grav... Myasthenia Grav... | Eculizumab | 6 Years - 17 Years | Alexion Pharmaceuticals, Inc. | |
| A Study to Evaluate the Efficacy of CV-MG01 (Myasterix) in Myasthenia Gravis | NCT03165435 | Myasthenia Grav... | CV-MG01 Placebo | 18 Years - | CuraVac | |
| Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG) | NCT04146051 | Myasthenia Grav... | Descartes-08 | 18 Years - | Cartesian Therapeutics | |
| Study of Telitacicept in Generalized Myasthenia Gravis | NCT05737160 | Myasthenia Grav... | Telitacicept Placebo | 18 Years - 80 Years | RemeGen Co., Ltd. | |
| A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis | NCT00683969 | Myasthenia Grav... | mycophenolate m... placebo | 18 Years - 80 Years | Hoffmann-La Roche | |
| A Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis | NCT04224506 | Myasthenia Grav... Myasthenia Grav... | No intervention | - | ProgenaBiome | |
| Predictors and Prognostic Factors of Myasthenia Gravis Outcome | NCT05214612 | Myasthenia Grav... Autoimmune Dise... Neuromuscular J... Thymoma Thymus Hyperpla... Nervous System ... Myasthenia Grav... Myasthenia Grav... Myasthenia Grav... Myasthenia Grav... Myasthenia Grav... Myasthenia Grav... | Drug treatment ... | 16 Years - | Assiut University | |
| Rituximab EfFicacy IN MyasthEnia Gravis (REFINE) | NCT05868837 | Myasthenia Grav... | Rituximab Placebo | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG | NCT03304054 | Myasthenia Grav... | Amifampridine P... Placebo Oral Ta... | 18 Years - | Catalyst Pharmaceuticals, Inc. | |
| Open-Label Extension of Tocilizumab in Subjects With Generalized Myasthenia Gravis | NCT05716035 | Myasthenia Grav... | Tocilizumab Inj... | 18 Years - 80 Years | Tang-Du Hospital | |
| Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis | NCT04115293 | Myasthenia Grav... | zilucoplan (RA1... Placebo | 18 Years - 74 Years | UCB Pharma | |
| A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis | NCT02473952 | Myasthenia Grav... | IGIV-C Placebo | 18 Years - 85 Years | Grifols Therapeutics LLC | |
| Open-Label Extension of Tocilizumab in Subjects With Generalized Myasthenia Gravis | NCT05716035 | Myasthenia Grav... | Tocilizumab Inj... | 18 Years - 80 Years | Tang-Du Hospital | |
| A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC) | NCT06282159 | Myasthenia Grav... | DNTH103 Placebo | 18 Years - 75 Years | Dianthus Therapeutics |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
